Brightsurf Science News & Current Events

October 03, 2004
Amgen investigational therapy, AMG 162, increased bone mineral density with twice yearly injection
Amgen Inc. (NASDAQ: AMGN) announced that at all doses studied, twice yearly injections of AMG 162, the company's investigational bone loss therapy, significantly increased bone mineral density at the total hip compared to placebo at 12 months.

Study showed vitamin D inadequacy highly prevalent among women treated for osteoporosis
-More than half of women currently treated for osteoporosis have suboptimal levels of vitamin D, according to new research presented today at the American Society for Bone and Mineral Research (ASBMR) meeting in Seattle.

Stress and aggression reinforce each other at the biological level
Scientists may be learning why it's so hard to stop the cycle of violence.

College students recognized & rewarded for their innovative work
The Collegiate Inventors Competition, a program of the National Inventors Hall of Fame, announces its 2004 winners.

Commandeering cellular machinery: recognition mechanism to detect small molecules
Researchers have learned how to commandeer the complex machinery that cells use to recognize and respond to such important molecules as steroid hormones, thyroid hormones and vitamin D. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to